menu
    • menu

    Company profile for Faron Pharmaceuticals

    NEW Drugs in Dev: 3
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces that, due to the prevailing Covid-19 situation, the Company's Board of Directors has decided to cancel the Company's annual general meeting ("AGM") scheduled to be held on 15 April 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Faron PharmaceuticalsFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Joukahaisenkatu 6 FI-20520 TURKU
    Telephone
    Telephone
    +358 2 469 5151
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.faron.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Faron Releases 2025 Financial Statements
    Faron Releases 2025 Financial Statements

    04 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-04/farons-financial-statements-release-1-january-to-31-december-2025

    PHARMIWEB
    04 Mar 2026
    Share Share
    Faron Pharma Releases 2025 Annual Report
    Faron Pharma Releases 2025 Annual Report

    04 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-04/correction-faron-pharmaceuticals-ltds-annual-report-2025-published

    PHARMIWEB
    04 Mar 2026
    Share Share
    Faron Secures Bexmarilimab Poster at BSH 2026 Meeting
    Faron Secures Bexmarilimab Poster at BSH 2026 Meeting

    23 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-23/farons-bexmarilimab-data-accepted-for-poster-presentation-at-the-bsh-annual-scientific-meeting-2026

    PHARMIWEB
    23 Feb 2026
    Share Share
    Faron Pharma: Extraordinary General Meeting Notice
    Faron Pharma: Extraordinary General Meeting Notice

    09 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-09/faron-pharmaceuticals-ltd-notice-to-the-extraordinary-general-meeting

    PHARMIWEB
    09 Feb 2026
    Share Share
    Immunotherapy Review Spotlights Clever-1 Inhibition
    Immunotherapy Review Spotlights Clever-1 Inhibition

    29 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-29/new-review-published-in-immunotherapy-highlights-the-potential-for-clever-1-inhibition-with-bexmaril

    PHARMIWEB
    29 Jan 2026
    Share Share
    Faron Expands Bexmarilimab Program With Phase I/II Trial
    Faron Expands Bexmarilimab Program With Phase I/II Trial

    27 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-expands-bexmarilimab-program-in-solid-tumors-with-a-randomized-phase-i%2fii-bexar-1130903

    ACCESSWIRE
    27 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search